Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Schnell Biopharmaceuticals,Inc. Announces Change of CEO

Monday, 23 Sep 2013 03:03am EDT 

Schnell Biopharmaceuticals,Inc. announced the change of Chief Executive Officer from Kim Jae Seop to Kim Jeong Chul, effective September 23, 2013. 

Company Quote

16.0 +3.68%
1 Aug 2014